20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T0864 | L-Thyroxine | Levothyroxine,NSC 36397,T4 | Thyroid hormone receptor(THR) , Endogenous Metabolite |
L-Thyroxine (NSC 36397) is the major hormone derived from the thyroid gland. L-Thyroxine (NSC 36397) is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in... | |||
T22355 | L-Thyroxine sodium | LT4 sodium,Levothyroxine sodium,L-T4 sodium | Thyroid hormone receptor(THR) |
L-Thyroxine sodium (LT4 sodium), the major hormone derived from the thyroid gland, is the agonist of Thyroid hormone receptor alpha and beta. | |||
T19572 | T4-ATA (S-isomer) | Others | |
T4-ATA S-isomer, the active form of the thyroid hormone, represents the S-isomer of T4-ATA. | |||
T20557 | Thyroxine sulfate | T4 Sulfate | |
Thyroxine sulfate is a sulfoconjugated derivative of Thyroxine and is also a metabolite of Thyroxine. | |||
T79925 | T4 UvsX Recombinase | DNA/RNA Synthesis | |
T4 UvsX Recombinase initiates DNA replication on double-stranded templates by catalyzing synapsis with a homologous primer single strand. It significantly enhances the snap-back (hairpin-primed) DNA synthesis catalyzed b... | |||
T79924 | T4 RNA ligase | DNA/RNA Synthesis | |
T4 RNA ligase is an enzyme that facilitates the ligation of single-stranded DNA. It is utilized for the synthesis of enzymatic oligoribonucleotides and the 3′-terminal labeling of RNA [1] [2]. | |||
T21383L | Dextrothyroxine sodium | Dextrotiroxina sodica,Lisolipin,D-T4 sodium | |
Dextrothyroxine sodium is the dextrorotary isomer of thyroxine. | |||
T33576 | N-Acetylthyroxine | N-Acetyl-L-thyroxine,N-Acetyl-T4 | |
N-Acetylthyroxine is a kind of Thyroxine analogue for the treatment of diagnosing and treating diabetes. | |||
T21383 | D-Thyroxine | Dethyrona,Detyroxin,Dextroid,Dextrothyroxine;Biotirmone,Dextroxin,Biotirmone,Debetrol,Dextrothyroxine | Others |
D-Thyroxine (Dextroxin) could lower cholesterol and also increases hepatic lipase which in turn improves utilization of triglycerides, leading to improve apolipoprotein E cholesterol particles. | |||
T69555 | XUN49524 | ||
XUN49524 also known as Vezf1-IN-T4, is an inhibitor of the pro-angiogenic activity of the zinc finger transcription factor Vezf1. XUN49524 was first reported in Molecules (2018), 23(7), 1615/1-1615/15 . This product has ... | |||
T5508 | PF-AKT400 | AKT protein kinase inhibitor | Akt |
PF-AKT400 (AKT protein kinase inhibitor) is a broadly selective and ATP-competitive inhibitor of Akt. | |||
T3110 | PRT4165 | NSC600157,PRT 4165 | BMI-1 , Others , E1/E2/E3 Enzyme |
PRT4165 (NSC600157) is a potent PRC1-mediated H2A ubiquitylation inhibitor. | |||
T77730 | QST4 | Antifungal | |
QST4 possessed antitubercular and antifungal activities with a MIC value of 6.25 μM in Mycobacterium tuberculosis Mycobacterium tuberculosis H37Rv. | |||
T67733 | BT44 | Others | |
BT44 is a novel, second-generation glial cell line_x0002_derived neurotropic factor mimetic with improved biological activity and is a lead compound for the treatment of neurodegenerative disorders. | |||
T10169 | 5-HT4 antagonist 1 | 5-HT Receptor | |
5-HT4 antagonist 1 is an antagonist of 5-HT4 (pKi = 9.6). | |||
T81399 | PRMT4-IN-2 | ||
PRMT4-IN-2 (compound 55) acts as a pan-inhibitor across various protein arginine methyltransferase (PRMT) isoforms, exhibiting inhibitory potencies with IC50 values of 92 nM for PRMT4, 436 nM for PRMT6, 460 nM for PRMT1,... | |||
T32036 | GYKI-T412 | GYKI-T 412,GYKI-T-412 | |
GYKI-T412 is small molecule agent with potential bioactivity. Detail information has not been published. | |||
T82464 | ENOS pT495 decoy peptide | ||
eNOS pT495 decoy peptide specifically inhibits T495 phosphorylation, thereby reducing eNOS uncoupling and mitochondrial redistribution. It is utilized in research on ventilator-induced lung injury [1]. | |||
T79208 | Oct4 inducer-2 | ||
Oct4 Inducer-2, an OCT4 inducer, sustains hiPSC formation by enhancing endogenous OCT4 expression and has applications in anti-aging research [1]. | |||
T72280 | PBT434 methanesulfonate | ||
PBT434 methanesulfonate is an orally active, potent α-synuclein aggregation inhibitor with the ability to cross the blood-brain barrier. Acting as an iron chelator, it modulates transcellular iron trafficking, inhibits i... |